GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (SHSE:603259) » Definitions » Quality Rank

Wuxi AppTec Co (SHSE:603259) Quality Rank


View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Wuxi AppTec Co Quality Rank Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuxi AppTec Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (SHSE:603259) » Definitions » Quality Rank
Comparable Companies
SZSE:300347 SHSE:603882 SZSE:300676 SHSE:603127 SZSE:300244 SHSE:603108 SZSE:300406 SZSE:300463 SZSE:300685 SZSE:300396 TMO DHR IDXX IQV A XSWX:LONN MTD ICLR ILMN LH
Traded in Other Exchanges
WUXAY:USA 02359:Hong Kong WX8:Germany
Address
288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, CHN, 200131
Website
https://www.wuxiapptec.com
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, gene therapies, and testing services for medical devices. Its segments comprise WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It generates the majority of its revenue from the WuXi Chemistry segment. Its geographic areas are the PRC, USA, Europe, and the Rest of the world, in which it generates the majority of its revenue from the USA.
Executives
Chen Shu Hui senior management
Yang Director
Hu Zheng Guo Director
senior management
Yao Chi Director
Chen Min Director
Zhu Bi Xin senior management
Yang senior management
Chen Shu Hui senior management
Hu Zheng Guo Director